Prevention of breast cancer in the context of a national breast screening programme
Anthony Howell(Breast Cancer Care), D. Gareth Evans(Manchester Academic Health Science Centre), Jane Warwick(St Mary's Hospital), Jack Cuzick(Queen Mary University of London), Ursula Beetles(Manchester Academic Health Science Centre), Alan Hufton(Manchester Academic Health Science Centre), Seniha Irem Sahin(Emory University), Mary Wilson(St Mary's Hospital), Ruth Warren(University of Cambridge), Helen McBurney(Manchester Academic Health Science Centre), B Eckersley(Manchester Academic Health Science Centre), William G. Newman(Manchester Metropolitan University), Michelle Harvie(Manchester Academic Health Science Centre), Paula Stavrinos(Breast Cancer Research Foundation), Susan Astley(University of Manchester), Iain Buchan(University of Liverpool), S. Ingham(University of Manchester), Jamie C. Sergeant(Manchester Academic Health Science Centre)
Cited by 37
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k